/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Secureworks Launches New Cybersecurity Analytics Application to Accelerate Threat Detection and Response
Red Cloak Threat Detection and Response Places the Skills of a
Pure-Play Cybersecurity Company in the Hands of In-House Security Teams
LAS VEGAS–(BUSINESS WIRE)–Secureworks® (NASDAQ: SCWX), a leading cybersecurity company that keeps
organizations safe in the digitally connected world, today announced the
launch of a software-as-a-service (SaaS) application that will transform
the way companies detect, investigate and respond to cyber threats.
Red Cloak Threat Detection and Response (TDR) is a security analytics
application that continuously applies more than 20 years of threat
intelligence and advanced analytics to customer endpoints, network and
cloud deployments. With deep learning and machine learning at its core,
Red Cloak TDR is designed to help customers detect advanced threats and
reduce their volume of alerts and false positives so they can identify
and respond to critical threats faster. Secureworks’ cloud-native
application speeds investigations with intuitive workflows and
automation, as well as a chat feature that gives users direct access to
Secureworks’ team of experienced cybersecurity experts. Subscribers will
also immediately benefit from the Secureworks network effect: When
Secureworks’ Counter Threat UnitTM identifies a new threat in
one of its 4200+ customer environments, a countermeasure will be made
available in the Red Cloak TDR application.
Security environments are often a collection of disconnected layers of
security products that leave gaps where threats can dwell
undetected for hundreds of days1. “Today’s well-armed
and coordinated adversaries operate in a collaborative and
sophisticated manner, yet the industry continues to rely on disparate
tools and siloed, manual investigations,” says Wendy
Thomas, SVP of Business and Product Strategy. “Red Cloak Threat
Detection and Response automates the investigation of high fidelity
alerts and integrates decades of experience, knowledge and threat
intelligence so enterprises can rapidly take the right action and reduce
business risk.”
Intuitive and responsive, Red Cloak TDR integrates Secureworks’ threat
intelligence which is compiled from billions of events across thousands
of security environments and continuously updated to include new and
emerging threats. Additionally, Red Cloak TDR integrates data from a
variety of third-party sources to give organizations the best possible
understanding of their threat landscape.
-
Red Cloak TDR analyzes activity from endpoint, network and cloud while
drastically reducing the number of false positives security
professionals face. It detects advanced threats by correlating
information from a variety of sources and threat intelligence feeds,
integrating Secureworks’ knowledge of threat actor behaviors, and
applying machine learning to provide much-needed context about the
threat. Red Cloak TDR builds trust in security alerts and frees
security teams to focus on threats that matter. -
Designed around Secureworks’ defense in concert methodology, Red Cloak
TDR unifies security environments and analyzes all relevant signals in
one place. Users gain additional context so they can quickly and
accurately judge the implications of each event. -
By seamlessly working on investigations together, teams can quickly
reach conclusions with confidence. The built-in chat feature can be
used right from the user interface during an investigation to get
expert help based upon years of experience hunting, analyzing and
defending against threats. -
The application allows for a quick, accurate, software-driven response
that gives users the ability to automate the right action. -
Because Red Cloak TDR is a cloud-based SaaS application, companies
won’t have the burden of installing on-premises hardware or
maintaining software version upgrades. Updates, backups and tuning are
covered. -
Red Cloak TDR does not charge by data consumption, so subscribers are
free to process the security-relevant data they need to keep their
organization safe. -
Onboarding is quick and easy because the application is designed to
easily integrate into an organization’s current control framework.
Red Cloak TDR is the first in a suite of Red Cloak SaaS solutions from
Secureworks to help enterprises reduce complexity in their security
operations and become more self-sufficient to defend against current and
emerging threats.
1. Secureworks Incident Response Insights Report, 2018
About Secureworks
Secureworks® (NASDAQ: SCWX) is a technology-driven cybersecurity leader
that protects organizations in the digitally connected world. Built on
proprietary technologies and world-class threat intelligence, our
applications and solutions help prevent, detect, and respond to cyber
threats. Red Cloak software brings advanced threat analytics to
thousands of customers and the Secureworks Counter Threat Platform
processes over 300B threat events per day. We understand complex
security environments and are passionate about simplifying security with
Defense in Concert so that security becomes a business enabler. More
than 4,000 customers across over 50 countries are protected by
Secureworks, benefit from our network effect and are Collectively
Smarter. Exponentially Safer. www.secureworks.com
Follow
@Secureworks on Twitter
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934 and
Section 27A of the Securities Act of 1933 and are based on Secureworks’
current expectations. Forward-looking statements in this press release
include statements related to expectations and beliefs regarding the Red
Cloak Threat Detection and Response application and the expected
capabilities and benefits of the application and future Red Cloak SaaS
solutions. Because forward-looking statements inherently involve risks
and uncertainties, actual future results may differ materially from
those expressed or implied by such forward-looking statements. These
risks and uncertainties include, but are not limited to, competitive
uncertainties and general economic and business conditions in
Secureworks’ markets as well as the other risks and uncertainties that
are described in Secureworks’ periodic reports and other filings with
the Securities and Exchange Commission, which are available for review
through the Securities and Exchange Commission’s website at www.sec.gov.
Any forward-looking statement speaks only as of the date as of which
such statement is made, and, except as required by law, we undertake no
obligation to update any forward-looking statement after the date as of
which such statement was made, whether to reflect changes in
circumstances or our expectations, the occurrence of unanticipated
events, or otherwise. Any future product, service, feature, benefit or
related specification referenced in this press release are for
information purposes only and are not commitments to deliver any
technology or enhancement.
Contacts
Secureworks Contact
Doreen Kelly Ruyak
[email protected]
202-744-9767
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
transfer
IMC to transfer its Oranim Pharmacy shares back to the seller
TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the seller.
“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”
About IM Cannabis Corp.
IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.
The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.
Disclaimer for Forward-Looking Statements
This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, the occurrence of growth opportunities and the likelihood of growth potential.
Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.
The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East
Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Company Contacts:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]
Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html
Cannabis
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
CCELL®
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
SHENZHEN, China, April 15, 2024 /PRNewswire/ — CCELL®, the world’s leading technology brand focused on creating trendsetting vape hardware products and advanced vaporization technology, today announced the launch of the Eco Star, the company’s all-in-one vaporizer focused on sustainability, wide-ranging oil compatibility, and ease of use.
The Eco Star’s casing material is made of biodegradable and plant-based PLA, a material that can be decomposed by bacteria or other living organisms. By adopting this type of eco-friendly casing, CCELL seeks to provide an option that can reduce the cannabis industry’s overall environmental impact and build a more sustainable society.
Built within the casing is a removable and recyclable lithium-ion battery. This thoughtful pull-apart design allows consumers to easily remove the battery before disposing of the casing, empowering them to contribute towards a greener Earth.
The Eco Star also features complete compatibility with all types of cannabis oils, clog-free dual air vents, and an isolated airway that ensures the cleanest possible vapor.
With increasing environmental challenges worldwide and tightening regulations on vape products, the Eco Star was introduced with the intention of raising environmental awareness across the industry.
The company has also implemented other measures to align its practices with its long-standing sustainability-focused values. These include offering biodegradable and plant-based PLA mouthpieces among its customization options. Additionally, the company uses energy-efficient aqueous processing in producing its patented ceramic heating cores to reduce greenhouse gas emissions.
Before the product’s official launch, CCELL provided their customers and consumers with an early look at the Eco Star at TPE24 and Hall of Flowers Ventura in the US, and Spannabis Barcelona in Spain.
Disclaimer for battery disposal: CCELL does not recycle lithium-ion batteries. Battery recycling requirements may vary by country, city, etc. Please contact your local recycling center for more details before disposal.
About CCELL®
CCELL® is a technology brand and global innovator in the portable vaporizer space that revolutionized the industry by introducing the ceramic heating component. CCELL® was born in the headquarters of Shenzhen Smoore Technology Limited, which has more than 10 years of expertise in the vaporization industry. With advanced R&D resources, patented technologies, strong production capabilities, and reliable quality control systems, CCELL® is recognized around the world for its exceptional vaporization technology and top-quality devices.
Learn more about CCELL® at www.ccell.com as well as on LinkedIn, Instagram, Facebook, Twitter, and YouTube.
Photo – https://mma.prnewswire.com/media/2386481/CCELL_Launches_Environmentally_Conscious_Eco_Star_AIO_Vaporizer.jpg
Logo – https://mma.prnewswire.com/media/2265752/CCELL_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/ccell-launches-environmentally-conscious-eco-star-aio-vaporizer-302116454.html
-
Avant2 weeks ago
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
-
StickIt1 week ago
StickIt Technologies Inc. Announces Year-End 2023 Financial Results
-
Cannabis1 week ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis1 week ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis1 week ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis1 week ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis1 week ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
Cannabis1 week ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services